Increasing quartiles of MEDLIFE index associated with reduced hazard ratios for all-cause, cancer mortality
Heart, Diabetes, Cancer Drugs on List for Medicare Price Negotiations, White House Says
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations
Fresh Produce Rx Tied to Improvements in Food Security, Cardiometabolic Outcomes
Clinically relevant improvements seen in glycated hemoglobin, blood pressure, and BMI for adults
ESC: Semaglutide Beneficial for HFpEF Patients With Obesity
Treatment with semaglutide led to larger reductions in symptoms and physical limitations, greater weight loss
ESC: Treating Iron Deficiency May Not Aid Heart Failure Patients
Study did not meet primary endpoint for composite of death, heart failure hospitalization, and exercise function
ESC: Mavacamten Cuts Need for Septal Reduction Tx with Hypertrophic Cardiomyopathy
Sustained improvements seen in left ventricular outflow tract gradients and symptoms